Boussard & Gavaudan Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$13.7M |
| 2 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$7.35M |
| 3 |
T-Mobile US
TMUS
|
+$7.15M |
| 4 |
Unity
U
|
+$4.86M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$4.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enovis
ENOV
|
+$3.6M |
| 2 |
OSG
Octave Specialty Group
OSG
|
+$2.13M |
| 3 |
FTAI Aviation
FTAI
|
+$308K |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$15.7K |
| 5 |
VG
Vonage Holdings Corporation
VG
|
+$9.97K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.77% |
| 2 | Technology | 6.48% |
| 3 | Communication Services | 3.35% |
| 4 | Industrials | 2.86% |
| 5 | Healthcare | 0.88% |
Similar funds
Boussard & Gavaudan Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Boussard & Gavaudan Investment Management held 169 positions worth $705K, up 28% from $551K the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Boussard & Gavaudan Investment Management deployed $37M of net new capital in Q3 2022, opening 34 new positions and adding to 12 existing holdings. Its largest new stake was CONTINENTAL RESOURCES INC.: 203,108 shares worth $13.6K.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Enovis, an estimated $3.6M trimmed.
- Boussard & Gavaudan Investment Management's largest Q3 2022 buy was CONTINENTAL RESOURCES INC.: 203,108 shares worth $13.6K.
- Boussard & Gavaudan Investment Management added most to Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q3 2022, an estimated $7.35M increase.
- Boussard & Gavaudan Investment Management's biggest Q3 2022 reduction was Enovis, cutting an estimated $3.6M.
- Boussard & Gavaudan Investment Management fully exited Change Healthcare Inc. Common Stock in Q3 2022, selling an estimated $15.7K.
- Boussard & Gavaudan Investment Management's ten largest holdings make up 38% of its $705K portfolio in Q3 2022.
- Boussard & Gavaudan Investment Management opened 34 new positions and closed 15 in Q3 2022.
- Boussard & Gavaudan Investment Management's portfolio value rose 28% quarter-over-quarter to $705K.
Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.